ArticleMolecular therapy oncolytics2022

Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime.

Canjing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.